These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

118 related items for PubMed ID: 7656815

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Soluble interleukin 2 receptor (sIL-2R) in patients with esophageal carcinoma].
    Duan ZF.
    Zhonghua Zhong Liu Za Zhi; 1993 Jan; 15(1):17-9. PubMed ID: 8334935
    [Abstract] [Full Text] [Related]

  • 3. Soluble interleukin-2 receptor in serum of patients with esophageal carcinoma.
    Jabłońska E, Kozłowski M, Pietruska Z, Furman M.
    Neoplasma; 1994 Jan; 41(6):315-8. PubMed ID: 7870214
    [Abstract] [Full Text] [Related]

  • 4. Relationship between serum levels of soluble interleukin-2 receptor and various disease parameters in patients with squamous cell carcinoma of the esophagus.
    Oka M, Hazama S, Takahashi M, Yamamoto K, Abe T, Yoshino S, Hayashi H, Tangoku A.
    Hepatogastroenterology; 1999 Jan; 46(28):2254-9. PubMed ID: 10521976
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Elevated serum levels of neopterin and soluble interleukin-2 receptor in patients with ovarian cancer.
    Gadducci A, Ferdeghini M, Malagnino G, Prontera C, Fanucchi A, Annicchiarico C, Bianchi R, Fioretti P, Facchini V.
    Gynecol Oncol; 1994 Mar; 52(3):386-91. PubMed ID: 8157196
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Clinical significance of measuring levels of tumor necrosis factor-alpha and soluble interleukin-2 receptor in nasopharyngeal carcinoma.
    Hsiao SH, Lee MS, Lin HY, Su YC, Ho HC, Hwang JH, Lee CC, Hung SK.
    Acta Otolaryngol; 2009 Dec; 129(12):1519-23. PubMed ID: 19922107
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum levels of soluble interleukin-2 receptor in patients with ANCA-associated vasculitis.
    Arranz O, Ara J, Rodríguez R, Saurina A, Mirapeix E, Darnell A.
    J Nephrol; 2000 Dec; 13(1):59-64. PubMed ID: 10720216
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. [Changes in serum IL-2 and sIL-2R levels in patients with primary hepatic carcinoma before and after treatment and their clinical significance].
    Wang M, Feng Y, Zhou X.
    Zhonghua Zhong Liu Za Zhi; 1995 Jan; 17(1):33-5. PubMed ID: 7656784
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.